.0001_Bottom Feeder

[WallStreetMyWay]

Going to a winner no doubt our stock has been under actuations its just a matter of time.

[NinjaMarinara]

ICNM - Getting ready to pop after the company has stated they are on their way to be a fully reporting company. Volume is building and your final chance at 0001s are fading.

[smallstockinvestor]

OSLH osl holding sub penny cannabis stock. Increasing volume.

[dcsteve]

MHYS .0001 produced "Exposed" movie with Television commercials sponsored by xfinity now playing nationwide!


http://www.ispot.tv/ad/AtuQ/xfinity-on-demand-exposed

[NoBidKid]

EGOH news out Sweratel AB and Pure Mobility International Inc., a wholly owned subsidiary of Eagle Oil Holding Company, Inc. announces a Distribution Agreement for Broadband Wireless Access Deployments

http://www.otcmarkets.com/stock/EGOH/news?id=101571

[Timboslice08]

PFMS constantly goes from .0002-.0008 almost weekly

[NoBidKid]

HNSS Healthnostics Obtains First Bio-Medical Application License Nanoparticle Technology Applies to Several Medical Field


NEW YORK, NY / ACCESSWIRE / January 14, 2015 / Healthnostics, Inc. (OTC Pink: HNSS) (PINKSHEETS: HNSS), announced it agreed to enter into its first bio-medical license agreement for nanoparticle therapeutic delivery applications. A "nanoparticle" is a particle exhibiting a diameter of 1-100 nanometers (billionths of a meter). The agreement allows Healthnostics to initiate an evaluation, identify ways to utilize the technology, identify development sources and create market applicability. This is the first license entered into under the Company's new Medical Therapeutic Initiative.
This nanoparticle technology is essentially a platform that can increase the efficiency of treatment and the way therapies are delivered for several medical fields. The licensed technology includes patented nanoparticles, nanoparticles producing nitric oxide (NPNO), paramagnetic nanoparticles and related technologies that have a range of applications that have application in dermatology, wound healing and can be applied for oncology purposes. The NPNO application has potential to be applied for the delivery of medical cannabis therapeutics.
About Healthnostics, Inc. (www.healthnostics.com)
Healthnostics is a medical and biotechnology analytics company with the mission of helping improve and participate in the delivery of healthcare by providing information resources for the medical and biotechnology fields.
Forward-Looking Statements
This press release may contain certain statements that are not descriptions of historical information, but are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Exchange Act of 1934. These forward-looking statements refer to matters that involve risks and uncertainties. Such statements reflect management's current views and are based on certain assumptions. Actual results could differ materially from the assumptions currently anticipated.
CONTACT:
Healthnostics, Inc.
Investor Relations
[e-mail]
SOURCE: Healthnostics, Inc.

(END)

[profithigh]

Updated BTZO DD...

BTZO
OTC Pink Current Information

Revenue:
? 3 Months Ending 30 Sept 2014 = $207,804 with a $48,696 Gross Margin = $159,108 total compared to 9,990 and Gross Margin of $0= $9,990 total the previous year
? Net Income = $37,283 compared to (-$396,110) the year prior

Authorized and Outstanding Share Structure:
? Total A/S = 4,200,000,000
? Total O/S = 1,397,110,507
? Total Preferred Authorized = 3,535,750
? Total Preferred O/S = 3,043,120
? Total float = O/S – Preferred O/S = 1,394,067,387
? Avg Volume (50 Day Period) = 94,016,137

Recent, Current, and Future Convertible Shares:

? On April 14, 2014, the Company issued an 8% convertible promissory note in the aggregate principal amount of $37,500 to an accredited investor. The note has a maturity date of January 18, 2015. The note is convertible into shares of our common stock at a conversion price of 59% of the average of the three (3) lowest per share market values during the ten (10) trading days immediately preceding a conversion date. During the nine months ended September 30, 2014, the Company recorded an interest expense of $1,398. The Company accounted for the conversion feature as a derivative valued at $48,244, of which $37,500 was recorded as a debt discount to be amortized over the life of the note. The remaining $10,744 was expensed immediately to interest expense. The balance of the note as of September 30, 2014 is $37,500 with accrued interest of $1,398.

? On May 5, 2014, the Company issued an 8% convertible promissory note in the aggregate principal amount of $32,500 to an accredited investor. The note has a maturity date of February 9, 2015. The note is convertible into shares of our common stock at a conversion price of 59% of the average of the three (3) lowest per share market values during the ten (10) trading days immediately preceding a conversion date. During the nine months ended September 30, 2014, the Company recorded an interest expense of $1,059. The Company accounted for the conversion feature as a derivative valued at $36,411, of which $32,500 was recorded as a debt discount to be amortized over the life of the note. The remaining $3,911 was expensed immediately to interest expense. The balance of the note as of September 30, 2014 is $32,500 with accrued interest of $1,059

? On August 20, 2014, the Company issued an 8% convertible promissory note in the aggregate principal amount of $20,500 to an accredited investor. The note has a maturity date of May 15, 2015. The note is convertible into shares of our common stock at a conversion price of 59% of the average of the three (3) lowest per share market values during the ten (10) trading days immediately preceding a conversion date. During the nine months ended September 30, 2014, the Company recorded an interest expense of $184. The Company accounted for the conversion feature as a derivative valued at $59,529, of which $20,500 was recorded as a debt discount to be amortized over the life of the note. The remaining $29,029 was expensed immediately to interest expense. The balance of the note as of September 30, 2014 is $20,500 with accrued interest of $184.

? On August 5, 2014 the Registrant entered into a Securities Purchase Agreement with 112359 Factor Fund, LLC (“Factor Fund”), pursuant to which the Registrant sold to Factor Fund a Secured Convertible Debenture. The Securities Purchase Agreement provides that Factor Fund will make ten payments, commencing with a payment of $80,000 on August 5, 2014, followed monthly by eight payments of $25,000 each and one $20,000 payment (i.e. total payments of $300,000). In exchange for each payment, an obligation in the principal amount equal to twice the payment will accrue and be represented by the Debenture. In addition, a premium of $50,000 will be added to the initial obligation, resulting in a total principal obligation accruing over the next nine months of $650,000. The primary terms of the Debentures are:
-- Interest will accrue on the principal balance at the lesser of 8% per annum or the applicable federal rate.
-- Principal and interest on each tranche will be due on the second anniversary of the payment date for that tranche.
-- The Registrant may prepay the principal amount of the Debenture, in whole or in part, at any time without penalty, and interest that has accrued on the prepaid amount will be waived.
-- The holder may convert the principal and interest accrued on the Debenture into common stock at a conversion price equal to 100% of the average of the five (5) lowest closing market prices for the common stock for the sixty trading days preceding conversion, but may not convert into a number of shares that would result in the holder owning beneficially more than 9.99% of the Registrant’s outstanding shares.
? The Registrant’s obligations under the Debenture are secured by a pledge of all of the Registrant’s assets. In addition, Hubert Blanchette and Marilu Brassington, who are officers and directors of the Registrant, have pledged a total of 666 shares of Series C Preferred Stock and 35,750 shares of Series D Preferred Stock to secure the Registrant’s obligations under the Debenture. The Company accounted for the conversion features as a derivatives valued at $226,088, of which $210,000 was recorded as a debt discount to be amortized over the life of the note, and $23,636 of which $20,500 was recorded as a debt discount to be amortized over the life of the note The remaining $16,088 and $3,136 were expensed immediately to interest expense. The balance of the note as of September 30, 2014 is $260,000 with accrued interest of $2,841.

? On August 5, 2014 the Registrant entered into a letter agreement with Factor Fund that modified the terms of the Secured Amended & Restated Convertible Debentures issued by the Registrant to Factor Fund on November 18, 2013 (the “A&R Debentures”). The modifications:
? -- increased the maximum number of shares that Factor Fund can hold upon conversion of the A&R Debentures from 4.99% of the outstanding to 9.99%.
? -- changed the period over which the conversion price will be measured from the 30 trading days preceding conversion to the 60 trading days preceding conversion.
? -- eliminated the restriction on the number of shares of common stock that Factor Fund can sell in a month.

Total Convertible Debt: $260,000 + 20,500 + 32,500 + 37,500 = $350,500 + interest

January 18, 2015: $37,500 / (.0002 x .59) = 317,796,610 shares diluted
February 9, 2015: $32,500 / (Uknown x .59) =
May 15, 2015: $20,500 / ( Uknown x .59) =
May 5, 2015: $260,000 due but is convertible at all times until paid in full or Mature Date

Link to 10Q: http://www.otcmarkets.com/edgar/GetFilingHtml?FilingID=10317538#FORM10Q_HTM_A_011

Always Trade on your own DD and never make a trade based on someone else's opinion of a stock

[NoBidKid]

PCFG on watch, 100 mil traded Friday, 10q out (not so great) but .0001's been getting tapped a bit since then

[profithigh]

Will look into it. Any DD regarding PMBS? It is usually the case where most DD doesn't really concern these types of stocks but it is refreshing to know what you are getting into prior to placing money into the stock.

For example, BTZO has a profitable net revenue over the last quarter and is still trading @ .0002. Great opportunity to get in now as they are looking to acquire more companies here shortly.

On the flip side NSEH has high volume but no 10Q and is limited information. IMO making NSEH a more trying to flip/in and out play instead of holding for a run.

[Super2013]

PMBS is also on the move

[profithigh]

Best Opportunity to "Front-Load" is ELRA

The accumulation on this ticker has recently began to rise. They may be converting some convertibles here recently. I am going to go back through the filing to see if any will be hitting the market here soon or have hit the market here recently.

The board has also recently began to show signs of enthusiasm. Bringing attention to the possibility that this ticker may run a little bit here in the near term. Perfect opportunity to get a good buy-order in early this week as on Friday the ticker went to no bid but only had 13 Mil on the bid by EOD. Good sign that early this week there is still opportunity to get in @ "Bottom Feeder" level here and really make out with some cash.

GLTA, Always do your own DD and never make a trade on some one else's opinion.

[profithigh]

Highest Accumulation is @ NSEH

The board is also showing enthusiasm and forward looking to a much higher pps. Seeing as at this level these stocks love to run on momentum and crowd popularity this may be the stock that runs the most. We will see.

Accumulation became divergent last week as the price went down to the .0002's but never did manage to hit the .0001 range.

Putting a buy-order @ .0002 early in the week could prove very beneficial by the end of the week as it seems that last week the people that accumulated have now begun to bring hope to the board that this will be having a run soon.

GLTA, Always do your own DD and never make a trade on some one else's opinion.

[profithigh]

Negative Accumulation for AVEW RECENTLY..

This is not a good sign that people have been buying the stock. Although the 25d Avg Volume shows an increase in activity the accumulation factor mixed in with this does not seem to indicate a move up here in the near term. Possibly lack of interest in the ticker.

The AVEW board seems to have a good bit of bashers on their as well.

Although I will keep on my watch list for this upcoming week I would definitely suggest caution towards trying to flip on this ticker.

GLTA, Always invest doing your own DD and never on some one else's opinion.

[profithigh]

AVEW: FRONT-LOAD (DD)

AVEW
OTC Pink Current Information

Revenue:

• 9 Months Ending 30 Sept 2014 = $410,865 with a $265,211 Gross Margin = $145,654 total with a (No previous year Comparison available on 10Q)
• Net Loss = (-$235,798) (No previous year Comparison available on 10Q)

Authorized and Outstanding Share Structure:

• Total A/S = 10,000,000,000
• Total O/S = 3,436,844,936 (534,465,864 Restricted)
• Subsequent Event Restricted Shares: 8,070,000
• Total Preferred Authorized = 50,000,000
• Total Preferred O/S = 100,000
• Total float = O/S – Preferred O/S = 2,894,209,072
• Avg Volume (50 Day Period) = 78,112,502

Recent, Current, and Future Convertible Shares:

Could Not Find Convertible Note Debts in 10Q.

Link to all information: http://www.otcmarkets.com/financialReportViewer?symbol=AVEW&id=128297

• Always do your own DD and NEVER trade on anyone elses comments or DD about the company you want to invest in.

[profithigh]

ELRA FRONT-LOAD (DD):

ELRA

OTC Pink Current Information

Revenue:

? 3 Months Ending 30 Sept 2014 = $67,318 with a $778,767 Gross Margin = (-$711,449) total compared to $0 and Gross Margin of $974,844 = (-$974,844) total the previous year
? Net Loss = (-$3,274,101) compared to (-$1,185,094) the year prior

Authorized and Outstanding Share Structure:

? Total A/S = 5,290,000,000
? Total O/S = 502,029,390
? Subsequent Events O/S = 513,529,390
? Total Preferred Authorized = 590,000,000
? Total Preferred O/S = 218,000,000
? Subsequent Event Preferred O/S = 280,000,000
? Total float = O/S – Preferred O/S = 167,500,000
? Avg Volume (50 Day Period) = 136,685,960

Recent, Current, and Future Convertible Shares:

- On January 30, 2014, the Company entered into a convertible promissory note with JSJ for $50,000 cash (the "Fourth JSJ Note"). The note bears interest at 10% and matured on January 30, 2015. Upon the maturity, the note has a cash redemption premium of 150% of the principal amount. The note is convertible to the Company’s common shares at a discount of 50% of the average of the three lowest bids on the twenty days before the date this note is executed, or 50% of the average of the three lowest bids during the twenty trading days preceding the delivery of any conversion notice, whichever is lower. During the nine months ended September 30, 2014, JSJ converted $50,000 of its fourth note to 41,172,878 shares of common stock and accrued interest of $2,754

- On August 21, 2014, the Company entered into a convertible promissory note with JSJ for $50,000 cash (the "Fifth JSJ Note"). The note bears interest at 12% and matured on February 21, 2015. Upon the maturity, the note has a cash redemption premium of 150% of the principal amount. The note is convertible to the Company’s common shares at a discount of 60% of the average of the three lowest bids on the twenty days before the date this note is executed, or 60% of the average of the three lowest bids during the twenty trading days preceding the delivery of any conversion notice, whichever is lower.

- On August 12, 2014, the Company entered into a convertible promissory note with KBM Worldwide Inc. (the "Fourth KBM Note") for $32,500. The note bears interest at 8% and matures on May 14, 2015. In the event that the note remains unpaid at that date, the Company will pay default interest of 22%. KBM has the right after a period of 180 days to convert the balance outstanding into the Company’s common stock at a rate equal to 40% of the average lowest three closing bid prices during the ten trading days prior to the conversion date.

- On March 6, 2014, the Company entered into a convertible promissory note with LG Capital Funding LLC (the "Second LG" Note) for $37,000. The note bears interest at 8% and matures on March 6, 2015. LG has the right after a period of 180 days to convert the balance outstanding into the Company’s common stock at a rate equal to 50% of the average lowest three trading prices during the fifteen trading days prior to the conversion date.

- On September 2, 2014, the Company entered into a convertible promissory note with Beaufort Capital Partners, LLC ("Beaufort") for $21,000. The note bears a total interest of $9,000 and matures on March 2, 2015. Absent the occurrence of an event of default, the Company may prepay the note for a net payment of $30,000 at any time prior to December 2, 2014. Beaufort has the right after the maturity date to convert the balance outstanding into the Company’s common stock at a rate equal to 50% of the lowest trading prices during the fifteen trading days prior to the conversion date. Under certain conditions, the conversion price would be reset to $0.0001 or 65% off the lowest price of the previous five trading days.

SUBSEQUENT EVENT NOTES:
- On October 1, 2014, the Company received funding from LG Capital Funding LLC (the "Second LG Backend" Note) for $37,000. The note bears interest at 8% and matures on March 6, 2015. LG has the right to convert the balance outstanding into the Company’s common stock at a rate equal to 50% of the average lowest three trading prices during the fifteen trading days prior to the conversion date.

- On October 2, 2014, the Company entered into a convertible promissory note with KBM Worldwide Inc. (the "Fifth KBM" note) for $37,500. The note bears interest at 8% and matures on May 14, 2015. In the event that the note remains unpaid at that date, the Company will pay default interest of 22%. KBM has the right after a period of 180 days to convert the balance outstanding into the Company’s common stock at a rate equal to 40% of the average lowest three closing bid prices during the ten trading days prior to the conversion date.

- On November 6, 2014, the Company entered into a convertible promissory note with Darling Capital, LLC. ("Darling") for $25,000. The principal was not received as of the filing date. The note bears interest at 8% and matures on August 6, 2015. Darling has the right after a period of 180 days to convert the balance outstanding into the Company’s common stock at a rate equal to 50% of the average of the three lowest trading price during the fifteen trading days prior to the conversion date.

- On November 7, 2014, the Company entered into a convertible promissory note with Auctus Private Equity Fund, LLC. ("Auctus") for $40,000. The principal was not received as of the filing date. The note bears interest at 8% and matures on August 7, 2015. In the event that the note remains unpaid at that date, the Company will pay default interest of 22%. Auctus has the right after a period of 180 days to convert the balance outstanding into the Company’s common stock at a rate equal to 50% of the average lowest two closing bid prices during the twenty-five trading days prior to the conversion date.

- On November 10, 2014, the Company entered into a convertible promissory note with KBM Worldwide Inc. (the "Sixth KBM" note) for $37,500. The principal was not received on as of the filing date. The note bears interest at 8% and matures on August 12, 2015. In the event that the note remains unpaid at that date, the Company will pay default interest of 22%. KBM has the right after a period of 180 days to convert the balance outstanding into the Company’s common stock at a rate equal to 40% of the average lowest three closing bid prices during the ten trading days prior to the conversion date.

Link to all information: http://www.otcmarkets.com/edgar/GetFilingHtml?FilingID=1031284

Always do your own DD and NEVER trade on anyone elses comments or DD about the company you want to invest in.

[profithigh]

BTZO: FRONT-LOAD (DD)

BTZO
OTC Pink Current Information

Revenue:
3 Months Ending 30 Sept 2014 = $207,804 with a $48,696 Gross Margin = $159,108 total compared to 9,990 and Gross Margin of $0= $9,990 total the previous year

Authorized and Outstanding Share Structure:
Total A/S = 4,200,000,000
Total O/S = 1,397,110,507
Total Preferred Authorized = 3,535,750
Total Preferred O/S = 3,043,120
Total float = O/S – Preferred O/S = 1,394,067,387
Avg Volume (50 Day Period) = 94,016,137

Recent, Current, and Future Convertible Shares:
No convertible notes found. All Convertibles are Preferred shares purchased as warrants with a sale price in the .20 range

Link to all information: http://www.otcmarkets.com/stock/BTZO/filings

Always do your own DD and NEVER trade on anyone elses comments or DD about the company you want to invest in.

[profithigh]

NSEH: FRONT-LOAD (DD)

NSEH
OTC Pink Limited Information

Revenue:
N/A

Authorized and Outstanding Share Structure:
Total A/S = 3,750,000,000
Total O/S = N/A
Total Preferred Authorized = 1,000,000
Total Preferred O/S = 87,000
Total float = O/S – Preferred O/S = N/A
Avg Volume (50 Day Period) = 127,542,655

Recent, Current, and Future Convertible Shares:
No 10Q or 10K filed to see any notes/debt

Link: http://www.otcmarkets.com/stock/NSEH/filings

?Always do your own DD and NEVER trade on anyone elses comments or DD about the company you want to invest in.

[profithigh]

AXCG: FRONT-LOAD (DD)

AXCG
OTC Pink Current Information

Revenue:
3 Months Ending 30 Sept 2014 = $138,818 with a $20,263 Gross Margin = $118,555 total compared to $16,579 and Gross Margin of $1,601 = 14,978 total the previous year
Net Loss = (-$603,034) compared to (-$316,974) the year prior


Authorized and Outstanding Share Structure:
Total A/S = 6,000,000,000
Total O/S = 3,154,189,761
Total Preferred Authorized = 15,000,000
Total Preferred O/S = 0
Total float = O/S – Preferred O/S = 3,154,189,761
Avg Volume (50 Day Period) = 78,112,502


Recent, Current, and Future Convertible Shares:

Carrying Value $699,427 as of 30 Sept 2014

-- "We can give no assurance that sufficient funding will be available on acceptable terms, or at all, and, if it is not, we may have to significantly reduce, or discontinue, our operations. To the extent that we raise additional funds by issuing equity securities or securities that are convertible into our debt securities, our stockholders may experience significant dilution"

-- "Of the $1,171,576 due to related parties, $185,227 was due May 1, 2012, and the Company is negotiating a settlement with the note holder; the remainder of the debt due to related parties, the majority of which has no specific repayment terms and is due on demand. The Company entered into an agreement in July 2014 with Chris Carey Advisors, LLC, an entity controlled by its CEO, Chris Carey, whereby $894,923 of debt was discounted to $744,923 in exchange for a convertible promissory note that provides for an interest rate and set share price on conversion (refer to form 8-k filed in conjunction with the agreement)."

Link: http://www.otcmarkets.com/edgar/GetFilingHtml?FilingID=10317181

Always do your own DD and NEVER trade on anyone elses comments or DD about the company you want to invest in.

[profithigh]

This Weeks Updated List to come prior to Opening Bell